425: CoreWeave-Core Scientific Acquisition Progresses

CoreWeave provides an update on the regulatory filings for its proposed acquisition of Core Scientific, with key documents now effective and mailed.

Summary

• CoreWeave, Inc. and Core Scientific, Inc. are progressing with the proposed acquisition.
• CoreWeave filed a registration statement on Form S-4 (No. 333-289742) on August 20, 2025, which was declared effective by the SEC on September 26, 2025.
• CoreWeave filed the related prospectus with the SEC on September 26, 2025.
• Core Scientific filed the definitive proxy statement with respect to the proposed transaction on September 26, 2025.
• The Prospectus and Proxy Statement were first mailed to Core Scientific stockholders on or about September 26, 2025.
• Investors and security holders are urged to read the Form S-4, Proxy Statement, Prospectus, and other relevant documents for important information about the proposed transaction.

Sentiment

Score: 6

Explanation: The filing is largely procedural, indicating positive progress in the regulatory steps for the acquisition. However, the extensive disclosure of risks associated with the transaction introduces a degree of caution, balancing the overall sentiment to moderately positive on process, but neutral on immediate financial impact.

Positives

• The Form S-4 registration statement was declared effective by the SEC, indicating regulatory progress for the acquisition.
• The definitive proxy statement and prospectus have been filed and mailed to Core Scientific stockholders, moving the transaction closer to a vote and potential completion.

Risks

• Uncertainty regarding the completion of the proposed transaction on anticipated terms or at all, and the timing of completion, including obtaining Core Scientific stockholder approval.
• Fluctuations in the market price of CoreWeave common stock could impact the value of consideration received by Core Scientific stockholders.
• Potential for unforeseen liabilities, future capital expenditures, and variations in anticipated revenues, expenses, earnings, and synergies.
• The possibility that anticipated benefits of the proposed transaction may not be realized or not within the expected time period.
• Challenges in successfully integrating CoreWeave and Core Scientific businesses and achieving anticipated synergies and value creation.
• Potential litigation relating to the proposed transaction against CoreWeave, Core Scientific, or their respective directors and officers.
• Disruptions from the proposed transaction harming CoreWeave's or Core Scientific's business, including current plans and operations, and diverting management's attention.
• Potential adverse reactions or changes to business relationships resulting from the announcement or completion of the proposed transaction.
• Impact of rating agency actions and the ability of CoreWeave and Core Scientific to access debt markets on a timely and affordable basis.
• Legislative, regulatory, and economic developments targeting public companies in the artificial intelligence, power, data center, and crypto mining industries.
• Potential business uncertainty, including the outcome of commercial negotiations and changes to existing business relationships during the pendency of the transaction.
• Restrictions during the pendency of the proposed transaction that may impact Core Scientific's ability to pursue certain business opportunities.
• Acts of terrorism, war, civil unrest, or other political/security disturbances.
• Dilution caused by CoreWeave's issuance of additional shares of its securities in connection with the proposed transaction.
• The transaction potentially being more expensive to complete than anticipated due to unexpected factors or events.
• Impacts of pandemics or other public health crises on people and economies.
• Global or regional changes in the supply and demand for power and other market or economic conditions.
• Changes in technical or operating conditions, including unforeseen technical difficulties.
• Development delays at CoreWeave and/or Core Scientific data center sites, particularly in converting crypto mining facilities to high-performance computing sites.

Future Outlook

Forward-looking statements address future business and financial events, conditions, expectations, plans, or ambitions, particularly concerning the consummation of the proposed transaction and its anticipated benefits. These statements are inherently uncertain and subject to risks, uncertainties, and assumptions that could cause actual results to differ materially from expectations. Neither CoreWeave nor Core Scientific assumes any obligation to publicly update these statements, except as required by law.

Management Comments

• Michael Intrator, Chief Executive Officer of CoreWeave, Inc., posted a communication on his LinkedIn account on October 16, 2025, in relation to CoreWeave's press release concerning the proposed acquisition of Core Scientific, Inc.

Industry Context

This acquisition represents a significant strategic move within the data center and high-performance computing (HPC) sectors. CoreWeave, a specialist in AI and HPC infrastructure, is acquiring Core Scientific, a major player in Bitcoin mining and data center operations. This transaction suggests a potential industry trend of converting existing data center capacity, including those previously used for crypto mining, to support the rapidly growing demand for AI and HPC workloads.

Legal Proceedings

• Potential litigation relating to the proposed transaction could be instituted against CoreWeave, Core Scientific, or their respective directors and officers.

Stakeholder Impact

• Shareholders of Core Scientific will be impacted by the proposed transaction, receiving CoreWeave common stock and warrants as consideration, and are urged to read the proxy materials before making voting or investment decisions.
• Shareholders of CoreWeave will experience dilution due to the issuance of additional shares and warrants in connection with the acquisition.
• Employees and management of both companies may face disruptions and diversions of attention due to transaction-related issues and potential integration challenges.
• Business relationships of both companies may experience adverse reactions or changes resulting from the announcement or completion of the proposed transaction.

Next Steps

• Core Scientific stockholders need to make voting or investment decisions after reviewing the Form S-4, Proxy Statement, Prospectus, and other relevant documents.
• Completion of the proposed transaction, subject to Core Scientific stockholder approval and other conditions.

Key Dates

Keywords

CoreWeave, Core Scientific, Acquisition, Merger, SEC Filing, Form 425, Form S-4, Proxy Statement, Prospectus, Artificial Intelligence, High-Performance Computing, Data Center, Crypto Mining